| Schedule of Computation of Net Loss Per Ordinary Share |
The following table sets forth the computation of net loss per ordinary share (in thousands, except share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Net loss |
|
$ |
(44,520 |
) |
|
$ |
(18,753 |
) |
|
$ |
(65,093 |
) |
|
$ |
(29,400 |
) |
Weighted-average number of common shares used in net loss per share applicable to ordinary shareholders, basic and diluted |
|
|
14,168,091 |
|
|
|
13,427,098 |
|
|
|
14,138,856 |
|
|
|
12,759,876 |
|
Net loss per share applicable to ordinary shareholders, basic and diluted |
|
$ |
(3.14 |
) |
|
$ |
(1.40 |
) |
|
$ |
(4.60 |
) |
|
$ |
(2.30 |
) |
|
| Schedule of Anti-dilutive Potential Ordinary Shares Excluded from Computation of Diluted net Loss Per Share |
The Company excluded the following potential ordinary shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Excluded securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Options to purchase ordinary shares |
|
|
1,743,735 |
|
|
|
1,125,008 |
|
|
|
1,743,735 |
|
|
|
1,125,008 |
|
Restricted stock units |
|
|
220,424 |
|
|
|
220,424 |
|
|
|
220,424 |
|
|
|
220,424 |
|
Unvested RSPAs |
|
|
3,072,999 |
|
|
|
3,264,603 |
|
|
|
3,072,999 |
|
|
|
3,264,603 |
|
Preferred stock (as converted to ordinary shares) |
|
|
14,226,483 |
|
|
|
13,323,745 |
|
|
|
14,226,483 |
|
|
|
13,323,745 |
|
Total ordinary shares equivalents |
|
|
19,263,641 |
|
|
|
17,933,781 |
|
|
|
19,263,641 |
|
|
|
17,933,781 |
|
|